dr donna h ryan glp 1 Expert Insight: Long-Term GLP-1 Use Often Necessary to Maintain Weight Loss, Health Benefits CRS 2017: Cardiometabolic Disease and

Wang Y, Kelly MA, Cowan TM, Longo N

In Table 1 , we present a summary of clinical studies regarding the effects of pregestational overweight and obesity on anatomical changes and poor neurodevelopmental outcomes

Eur J Pharmacol 794:127134 Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, DAgostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, Kane D, OConnor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MN, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, Machold KP, Conaghan PG, Group OSI (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology

The doctor may need to consider prior dose, side effects, current appetite, blood sugar status, constipation or nausea history, hydration, weight trajectory, lab markers, cost, access, and maintenance goals

Both Rybelsus and Farxiga can cause low blood sugar (hypoglycemia) when taken with insulin or insulin-releasing medications like sulfonylureas (e.g., glipizide and glyburide)